Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 USD | -3.67% | -8.70% | +21.39% |
May. 08 | Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Reports Q1 Revenue $33.1M, vs. Street Est of $34.5M | MT |
May. 08 | Transcript : Karyopharm Therapeutics Inc., Q1 2024 Earnings Call, May 08, 2024 |
Financials (USD)
Sales 2024 * | 145M | Sales 2025 * | 166M | Capitalization | 124M |
---|---|---|---|---|---|
Net income 2024 * | -146M | Net income 2025 * | -138M | EV / Sales 2024 * | 0.85 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
-0.85
x | P/E ratio 2025 * |
-1.27
x | Employees | 325 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.64% |
Latest transcript on Karyopharm Therapeutics Inc.
1 day | -3.67% | ||
1 week | -8.70% | ||
Current month | +1.94% | ||
1 month | -0.94% | ||
3 months | -15.32% | ||
6 months | +42.20% | ||
Current year | +21.39% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 56 | 20-02-25 |
Mike Mason
DFI | Director of Finance/CFO | 49 | 19-02-24 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 13-10-02 |
Barry Greene
BRD | Director/Board Member | 60 | 12-12-31 |
Director/Board Member | 59 | 13-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.02% | 1,487 M€ | +8.80% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 1.05 | -3.67% | 939,923 |
24-05-23 | 1.09 | -1.80% | 951,124 |
24-05-22 | 1.11 | -0.89% | 1,061,039 |
24-05-21 | 1.12 | -1.75% | 1,222,994 |
24-05-20 | 1.14 | -0.87% | 1,234,041 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.39% | 124M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- KPTI Stock